These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1554383)
1. Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine. Gerson SL; Berger NA; Arce C; Petzold SJ; Willson JK Biochem Pharmacol; 1992 Mar; 43(5):1101-7. PubMed ID: 1554383 [TBL] [Abstract][Full Text] [Related]
2. Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Gerson SL; Zborowska E; Norton K; Gordon NH; Willson JK Biochem Pharmacol; 1993 Jan; 45(2):483-91. PubMed ID: 8435098 [TBL] [Abstract][Full Text] [Related]
3. Modulation of nitrosourea resistance in myeloid leukemias. Gerson SL; Trey JE Blood; 1988 May; 71(5):1487-94. PubMed ID: 3258773 [TBL] [Abstract][Full Text] [Related]
4. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU. Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444 [TBL] [Abstract][Full Text] [Related]
5. Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Dolan ME; Pegg AE; Moschel RC; Grindey GB Biochem Pharmacol; 1993 Jul; 46(2):285-90. PubMed ID: 8347150 [TBL] [Abstract][Full Text] [Related]
6. Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea. Pegg AE; Swenn K; Chae MY; Dolan ME; Moschel RC Biochem Pharmacol; 1995 Oct; 50(8):1141-8. PubMed ID: 7488227 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase. Gerson SL; Trey JE; Miller K Cancer Res; 1988 Mar; 48(6):1521-7. PubMed ID: 3162197 [TBL] [Abstract][Full Text] [Related]
8. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Liu L; Markowitz S; Gerson SL Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088 [TBL] [Abstract][Full Text] [Related]
9. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance. Gerson SL; Willson JK Hematol Oncol Clin North Am; 1995 Apr; 9(2):431-50. PubMed ID: 7642472 [TBL] [Abstract][Full Text] [Related]
10. O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines. Silber JR; Bobola MS; Ewers TG; Muramoto M; Berger MS Oncol Res; 1992; 4(6):241-8. PubMed ID: 1421617 [TBL] [Abstract][Full Text] [Related]
11. Combined depletion of O6-alkylguanine-DNA alkyltransferase and glutathione to modulate nitrosourea resistance in breast cancer. Gerson SL; Berger SJ; Varnes ME; Donovan C Biochem Pharmacol; 1994 Aug; 48(3):543-8. PubMed ID: 8068041 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of human colon tumour cell lines to carmustine by depletion of O6-alkylguanine-DNA alkyltransferase. Magull-Seltenreich A; Zeller WJ J Cancer Res Clin Oncol; 1995; 121(4):225-9. PubMed ID: 7751321 [TBL] [Abstract][Full Text] [Related]
13. Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea. Mitchell RB; Dolan ME Cancer Chemother Pharmacol; 1993; 32(1):59-63. PubMed ID: 8462125 [TBL] [Abstract][Full Text] [Related]
14. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. KoƧ ON; Reese JS; Davis BM; Liu L; Majczenko KJ; Gerson SL Hum Gene Ther; 1999 Apr; 10(6):1021-30. PubMed ID: 10223735 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer. Liu L; Schwartz S; Davis BM; Gerson SL Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916 [TBL] [Abstract][Full Text] [Related]
16. Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea. Loktionova NA; Pegg AE Cancer Res; 1996 Apr; 56(7):1578-83. PubMed ID: 8603405 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154 [TBL] [Abstract][Full Text] [Related]
18. Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU. Gerson SL; Phillips W; Kastan M; Dumenco LL; Donovan C Blood; 1996 Sep; 88(5):1649-55. PubMed ID: 8781420 [TBL] [Abstract][Full Text] [Related]
19. The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytes. Trey JE; Gerson SL Cancer Res; 1989 Apr; 49(8):1899-903. PubMed ID: 2702633 [TBL] [Abstract][Full Text] [Related]
20. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Marathi UK; Dolan ME; Erickson LC Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]